🇭🇳

US Tariffs on Pharmaceutical Products from Honduras — 10% (2026)

Tariff Rate Breakdown

10%

Section 122 Base

10%

Total Effective Rate

CAFTA-DR — qualifying goods may enter duty-free

Pharmaceutical Products from Honduras represent an important segment of bilateral trade, with approximately $6B in total bilateral trade.

Following the Supreme Court's landmark February 20, 2026 decision striking down IEEPA tariffs, imports of pharmaceutical products from Honduras are now subject to a 10% tariff under Section 122 of the Trade Act of 1974, effective February 24, 2026.

This 10% rate has a built-in expiration: Section 122 limits presidential tariff authority to 150 days, meaning the tariff expires approximately July 24, 2026 without congressional renewal.

Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, with the Section 122 tariff as the primary duty. No additional Section 232 or Section 301 surcharges apply to most products in this category from Honduras.

Honduras is party to the CAFTA-DR, which may provide preferential or duty-free access for qualifying pharmaceutical products. Importers should verify rules of origin requirements to take advantage of preferential rates.

Key products in HTS Chapter 30 imported from Honduras include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.

Common Products in Chapter 30

VaccinesAntibioticsInsulinBandagesDiagnostic reagentsBlood productsPharmaceutical dosage formsFirst-aid kits

Calculate Your Import Duty

Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Honduras.

Open Tariff Calculator

Frequently Asked Questions

What is the current tariff rate on pharmaceutical products from Honduras?

As of March 2026, pharmaceutical products from Honduras face a base tariff of 10% under Section 122. The effective rate can be up to 10%.

Will the tariff on pharmaceutical products from Honduras change?

The Section 122 tariff of 10% expires approximately July 24, 2026, unless Congress extends it. Monitor legislative developments for updates.

How did the Supreme Court ruling affect pharmaceutical products imports from Honduras?

The Supreme Court's February 20, 2026 ruling struck down IEEPA reciprocal tariffs as exceeding presidential authority. The president signed a replacement 10% tariff under Section 122 the same day, effective February 24. Qualifying goods under CAFTA-DR may still enter duty-free.